title: Effects of pentoxifylline on the adherence of polymorphonuclear neutrophils to oxidant-stimulated human endothelial cells: involvement of cyclic AMP.
abstract: Cultured human umbilical vein endothelial cells (HUVECs) treated with reactive oxygen species (ROS) show increased adherence of polymorphonuclear leukocytes (PMNs). Because pentoxifylline (PTX) is known to inhibit cell interactions, we studied PMN adherence to ROS-stimulated HUVECs pretreated with PTX. ROS were generated by the oxidation of hypoxanthine by xanthine oxidase, giving rise to superoxide anion and hydrogen peroxide. Human PMNs were then added to HUVEC monolayers. After various times, the cultures were washed and the number of adherent PMNs was estimated by measuring myeloperoxidase in the total cell homogenate. PTX inhibited adherence in a concentration-dependent manner. Moreover, the increase in intracellular cAMP content varied with the PTX concentration. Isobutylmethylxanthine (IBMX) and isoproterenol (ISO) which increase intracellular cAMP content, also inhibited the adherence of PMNs to ROS-stimulated HUVECs. We conclude that cAMP is probably involved in the intracellular regulation of ROS-mediated PMN adherence to endothelial cells.
authors.affiliation: Unité INSERM 294, CHU X, Bichat Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Franzini
authors.forename: H
authors.initials: H
authors.lastname: Sellak
authors.forename: C
authors.initials: C
authors.lastname: Babin-Chevaye
authors.forename: J
authors.initials: J
authors.lastname: Hakim
authors.forename: C
authors.initials: C
authors.lastname: Pasquier
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D016877:Oxidants / Q000494:pharmacology*; D010431:Pentoxifylline / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000494:pharmacology
chemical_list: D000318:Adrenergic beta-Agonists; D016877:Oxidants; D010726:Phosphodiesterase Inhibitors; D017382:Reactive Oxygen Species; D000242:Cyclic AMP; D007545:Isoproterenol; D010431:Pentoxifylline; D015056:1-Methyl-3-isobutylxanthine